|
AnesthesiaWeb and the Society for Critical Care Medicine
present...
Supported by an unrestricted educational grant from Abbott Laboratories.
This CME/ACPE-accredited, expert panel discussion examines sedative
options and adjunctive drug management approaches to achieving
a calm, comfortable, cooperative and communicative patient.
|
| Introduction and Overview |
|
|
|
Robert W. Taylor, MD,
FCCM
Program Chair
Clinical Professor and Director
Critical Care Training Program
Saint Louis University
St John's Mercy Medical Center
St Louis, Missouri |
| Problems and Solutions in Weaning the Vented Patient |
|
|
|
Richard R. Riker, MD
Assistant Chief, Department of Critical Care
Maine Medical Center
Portland, Maine |
| Clinical Experience With the Use of Alpha-2 Adrenergic
Agonists for Sedation |
|
|
|
Daniel L. Herr, MS,
MD, FCCM
Medical Director, Surgical Critical Care
Washington Hospital Center
Director of Surgical Critical Care Research
Medstar Research Institute
Washington, DC |
| Questions and Answers |
|
|
|
| Alpha-2 Adrenergic Agonists for Sedation and Analgesia |
|
|
Click
to View SlideShow |
Learning Objectives:
- Review the sedative options for neurosurgical patients, nonintubated,
agitated patients, and those patients who are difficult to wean
from the ventilator
- Review and discuss the use of alpha-2 adrenergic agonists
to avoid respiratory depression in sedation
- Summarize drug management techniques to achieve a calm, comfortable,
cooperative and communicative patient.
The Society of Critical Care Medicine designates this activity for a maximum
of 1 credit hour in Category 1 of the Physician's Recognition Award of the
American Medical Association.
|
| Proceed to Post Test and
Evaluation |
